VCAN and non-small cell lung carcinoma: The results suggested that when plasma exosomal versican ≥ 211.44 pg/ml, the risk of NSCLC was higher, indicating that the value and significance of detecting plasma exosomal protein was greater in the early diagnosis of lung cancer and might be related to the envelopment of exosomes that made the versican protein more stable.